goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon

NEI Podcast

Neuroscience Education Institute

The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.

1 Listener

share icon
not bookmarked icon

All episodes

Best episodes

Top 10 NEI Podcast Episodes

Best episodes ranked by Goodpods Users most listened

What is the difference between psychopathy and antisocial personality? What is known about gender differences when it comes to antisocial personality disorder?

In this episode, Dr. Andrew Cutler interviews Dr. James Knoll about how to diagnose and treat antisocial personality disorder.

With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on decriminalizing mental illness.

Episodes to be released under this theme include:

Part 1: Decriminalizing Mental Illness with Dr. Katherine Warburton

Part 2: The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment with Dr. James Knoll

Part 3: Intensive Level Care for Violent Patients with Serious Mental Illness with Dr. Carolina Klein

Subscribe to the NEI Podcast, so that you don’t miss another episode!

1 Listener

bookmark
plus icon
share episode

In this episode, Dr. Andrew Cutler interviews Dr. Karl Doghramji on best practices for the treatment and management of insomnia.

Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD22-Sleep

Learning Objectives: After completing this educational activity, you should be better able to:

  • Utilize assessment tools in the diagnosis of insomnia
  • Address challenges in the pharmacologic treatment of insomnia
  • Implement evidence-based pharmacological treatments for insomnia

Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A posttest score of 70% or higher is required to receive CME/CE credit. The content in this activity pertains to pharmacology and is worth 1.0 continuing education hour of pharmacotherapeutics.

Credit Types. The following are being offered for this activity:

  • Nurse Practitioner: ANCC contact hours
  • Pharmacy: ACPE application-based contact hours
  • Physician: ACCME AMA PRA Category 1 Credits TM
  • Physician Assistant: AAPA Category 1 CME credits
  • Psychology: APA CE credits
  • Social Work: ASWB-ACE CE credits
  • Non-Physician Member of the Healthcare Team: Certificate of Participation stating the program is designated for AMA PRA Category 1 Credits TM

Peer Review: The content was peer-reviewed by an MD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity.

Disclosures: All individuals in a position to influence or control content were required to disclose all relevant financial relationships. Any potential conflicts of interest were identified and mitigated prior to the activity being planned, developed, or presented.

I nterviewerAndrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Carlsbad, CAConsultant/Advisor: AbbVie, Acadia, AiCure, Alfasigma, Alkermes, Allergan, Atentiv, Cognitive Research, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sage, Sunovion, Supernus, Takeda, Teva Speakers Bureau: AbbVie, Acadia, Alkermes, Allergan, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Teva, Tris

IntervieweeKarl Doghramji, MDProfessor, Department of Psychiatry & Human Behavior; Associate Professor, Departments of Neurology and of Medicine; Medical Director, Jefferson Sleep Disorders Center; Program Director, Fellowship in Sleep Medicine; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PAResearch/Grant: Harmony, Inspire Consultant/Advisor: Axsome, Eisai, Jazz, Harmony, Idorsia, Imbrium, Inspire Stockholder: Merck

Pre-Interview AuthorSabrina K. Bradbury-Segal, PhDMedical Writer, Neuroscience Education Institute, Carlsbad, CANo financial relationships to disclose.

The Planning Committee and Peer Reviewer have no financial relationships to disclose.

Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.

Cultural Linguistic Competencies and Implicit Bias: A variety of resources addressing cultural and linguistic competency, and strategies for understanding and reducing implicit bias can be found in this handout.

Support: This activity is supported by an unrestricted educational grant from Eisai.

Released: August 31, 2022 CE credit expires: August 31, 2025

1 Listener

bookmark
plus icon
share episode

Healthcare workers on the frontline, working to save patients with the COVID-19 virus, during this pandemic have been especially vulnerable to mental health consequences and trauma. In the early stages of the global shut-down, Dr. Mona Masood launched the Physician Support Line, a volunteer hotline to support physicians and healthcare providers who were on the frontlines, battling the virus, and the traumatic consequences of doing so, simultaneously. Doctors, nurses, EMTs and other health care workers have been under extremely stressful conditions, increased patient loads without necessary staffing, a lack of personal protective equipment (PPE), and overtime hours, placing them at high risk for contracting the virus themselves. Many have lost colleagues to the virus. In this episode, learn what inspired her to create this hotline, what it has done for physicians, and how you can get involved.

Dr. Mona Masood is board certified in general adult psychiatry and is an outpatient psychiatrist in the Ivyland, Pennsylvania area. She is also the founder of the Physician Support Line and a Board Member of the nonprofit Muslim Wellness Foundation, which provides mental health educational services to the community. For more information on the Physician Support Line please go to: https://www.physiciansupportline.com/

bookmark
plus icon
share episode

What is the prevalence of bipolar disorder in the pediatric population and does this change, depending on age? What are important tips for recognizing hypomania in children, and diagnosing children with mixed depression? In this episode, we address these questions and more with pediatric psychiatrist, Dr. Manpreet Singh.

Dr. Singh is Associate Professor of Psychiatry and Behavioral Sciences at Stanford University, and leads a program aimed to accelerate understanding and treatment in youth with or at high risk for developing lifelong mood disorders. She is the director of the Pediatric Mood Disorders Program and the Pediatric Emotion and Resilience Program at Stanford University.

Dr. Singh earned her MD at Michigan State University and her MS at University of Michigan. She completed her combined residency training in Pediatrics, Psychiatry, and Child and Adolescent Psychiatry at Cincinnati Children’s Hospital Medical Center. After two years of T32 postdoctoral training at Stanford’s Center for Interdisciplinary Brain Sciences Research, she joined the faculty in 2009.

Dr. Singh leads a multidisciplinary team that evaluates and treats youth with a spectrum of mood disorders as young as age 2 and well into their 20s. Her NIMH and industry funded studies examine mechanisms underlying mood disorders and apply cutting edge strategies to directly modulate the brain using transcranial magnetic stimulation and real time neurofeedback. She is also investigating the efficacy and safety of pharmacotherapies and psychotherapies, such as family focused psychotherapy and mindfulness meditation, to reduce mood symptoms and family stress. All of these areas of research aim to elucidate core mechanisms underlying mood disorders and how treatment early in life can pave the path to more adaptive outcomes.

In her spare time, Dr. Singh enjoys traveling and hiking with her husband and three children, and avidly teaches Indian classical music. Her clinical handbook for the diagnosis and treatment of pediatric mood disorders can be found at the link below:

https://appi.org/Products/Mood-Disorders/Clinical-Handbook-for-the-Diagnosis-and-Treatment?SearchText=clinical%20handboo&sku=37174

bookmark
plus icon
share episode

Healthcare disparities occur around the world, due to a complex, multifaceted situation that results from socioeconomic hardships, psychosocial stress, and cultural differences. In the United States, these disparities are often seen in minority communities, such as Hispanics and Black Americans. When a pandemic, such as COVID-19 occurs, it can expose these disparities in the most tragic ways. Current statistics surrounding healthcare disparities during the pandemic are staggering, suggesting that COVID-19 has disproportionately impacted the Black American community. In this important and timely interview with Dr. Napoleon Higgins, we address your most pressing questions on why this is occurring, and how awareness can improve this situation for future generations.

Dr. Napoleon Higgins, Jr., is a psychiatrist in the Houston/Clear Lake City Area. He currently serves as Owner, CEO and President of Bay Pointe Behavioral Health Service, Inc., and South East Houston Research Group, Inc. He also practices as the Medical Director of Hold My Hand Residential Treatment Center. Dr. Higgins specializes in treating mental health disorders through medication management, psychotherapy and behavioral training.

bookmark
plus icon
share episode

Food and beverages interact with certain psychiatric medications to alter their pharmacokinetic properties, resulting in potentially unintended health outcomes. In this podcast episode, Dr. Rajnish Mago describes common food and beverages that interact with psychiatric medication and provides recommendations for avoiding unintended food-drug interactions.

Optional CME credits / certificate instructions: After listening to the podcast, to take the optional posttest and receive CME credit, click HERE.

Learning Objectives: After completing this educational activity, you should be better able to:

  • Describe the effects of food on the bioavailability of certain psychotropic medications Discuss current evidence of the brain-gut connection’s impact on mental health
  • Describe the effects of vitamin C, caffeine, and grapefruit on the pharmacokinetics of certain psychotropic medications

Accreditation and Credit Designation Statements: The Neuroscience Education Institute (NEI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NEI designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A posttest score of 70% or higher is required to receive CME credit.

Nurses and Physician Assistants: for your CE requirements, the ANCC and NCCPA will accept AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME. The content in this activity pertains to pharmacology and is worth 0.75 continuing education hour of pharmacotherapeutics.

Peer Review: The content was peer-reviewed by a PharmD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME activity.

Disclosures: All individuals in a position to influence or control content are required to disclose all relevant financial relationships. Although potential conflicts of interest are identified and resolved prior to the activity being presented, it remains for the participant to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.

Faculty Interviewer / Author

Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY

Grant/Research: Acadia, Alkermes, Allergan, Axsome, Biohaven, Intra-Cellular, Lundbeck, Novartis, Otsuka, Sage, Sunovion, Tris

Consultant/Advisor: Acadia, AiCure, Alfasigma, Alkermes, Allergan, Avanir, Intra-Cellular, Ironshore, Janssen, Lundbeck, MedAvante-ProPhase, Neurocrine, Novartis, Otsuka, Sage, Sunovion, Takeda, Teva, Tris

Speakers Bureau: Acadia, Alkermes, Allergan, Avanir, Ironshore, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Takeda, Teva, Tris

Faculty Interviewee / Author

Rajnish Mago, MD

Clinical Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY

Travel Expenses: Intas Pharmaceuticals (for Indian Psychiatric Association annual meeting)

Stockholder: Johnson and Johnson

Pre-Interview Author

Sabrina K. Bradbury-Segal, PhD

Medical Writer, Neuroscience Education Institute, Carlsbad, CA

No financial relationships to disclose.

The Planning Committee and Peer Reviewer have no financial relationships to disclose.

Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.

Cultural and Linguistic Competency: A variety of resources addressing cultural and linguistic competency can be found in this linked handout.

Support: This activity is supported solely by the provider, NEI.

Released: May 11, 2020 CME credit expires: May 11, 2023

bookmark
plus icon
share episode

What is the evidence that exercise is at least as effective as medications for the treatment of mental health disorders, such as depression? Can you share any research findings on the effects of exercise for patients with traumatic brain injury? If you have questions like these, you won't want to miss this episode with psychiatrist and renowed author, Dr. John Ratey!

Best selling author, John J. Ratey, MD, is an Associate Clinical Professor of Psychiatry at Harvard Medical School and an internationally recognized expert in Neuropsychiatry. He has published over 60 peer-reviewed articles, and 11 books published in 17 languages, including the groundbreaking ADD-ADHD “Driven to Distraction” series with Ned Hallowell, MD. With the publication of "Spark-The Revolutionary New Science of Exercise and the Brain," Dr. Ratey has established himself as one of the world's foremost authorities on the brain-fitness connection. His most recent book, “Go Wild” explores how we can achieve optimal physical and mental health by getting in touch with our caveman roots, and how we can “re-wild” our lives. Recognized by his peers as one of the Best Doctors in America since 1997, Dr. Ratey was recently honored by the Massachusetts Psychiatric Society as "Outstanding Psychiatrist of the Year" for advancing the field. Dr. Ratey and his work are frequently profiled in the media, where he’s been featured on ABC, CBS, NBC, PBS and NPR, as well as in The New York Times, Newsweek, The Washington Post, US News and World Report, Men’s Health, and other national publications.

bookmark
plus icon
share episode

With the recent COVID-19 pandemic, mental health concerns are on the rise. What do we know about the relationship between suicide risk and previous pandemics or natural disasters? How do we distinguish between behavior that seems like appropriate coping during this time and behavior that should raise a red flag? What are some protective factors against suicide, and how can we capitalize on these, especially during this challenging time? Join us, as we interview the Chief Medical Officer of the American Foundation for Suicide Prevention (AFSP), Dr. Christine Moutier.

Dr. Moutier knows the impact of suicide firsthand. After losing colleagues to suicide, she dedicated herself to fighting this leading cause of death. Throughout her career she has focused on fighting stigma related to mental health and help seeking. Training healthcare leaders, physicians, and advocacy groups, Dr. Moutier has sought to change the healthcare system’s approach to mental health, in order to optimize care for those suffering from mental health conditions.

As a leader in the field of suicide prevention, Dr. Moutier joined AFSP in 2013, and has revitalized AFSP’s Education team, re-launched its Loss & Healing department, and expanded AFSP’s support to include those with lived experience of suicide.

Moutier has authored articles and book chapters for publications such as the Journal of the American Medical Association, Academic Medicine, the American Journal of Psychiatry, the Journal of Clinical Psychiatry, Psychiatric Times, Depression and Anxiety, and Academic Psychiatry.

She has testified before the U.S. Congress and spoken at the White House, she was the host of AFSP’s documentary on surviving suicide loss, The Journey, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, the BBC, NBC, CNN , and other print and television outlets.

You can follow Dr. Moutier on Twitter at @cmoutierMD.

For more information on the AFSP please visit: afsp.org

bookmark
plus icon
share episode

Given the recent COVID-19 virus pandemic, how is pediatric anxiety influenced by things like the media, parental attitudes, and the family environment? How effective is telepsychiatry for pediatric patients? If you have these types of questions you won't want to miss this timely and important interview with psychiatrist Dr. Jeffrey Strawn! In this episode, we discuss issues like effective communication strategies for parents during this time, and how to best meet the needs of pediatric patients with anxiety.

Dr. Strawn is an Associate Professor of Psychiatry and Pediatrics at the University of Cincinnati and at Cincinnati Children’s Hospital. He directs the University of Cincinnati Anxiety Disorders Research Program. His ongoing research explores the pathophysiology and psychopharmacology of anxiety disorders, using functional neuroimaging and magnetic resonance spectroscopy. His research further aims to identify early predictors of treatment response in anxiety and to identify which patients may respond best to which specific treatments. In his clinical practice, he works with youth with anxiety disorders and with their parents and families.

bookmark
plus icon
share episode

Methamphetamine is an extremely serious problem in the United States, and it remains one of the most commonly misused stimulant drugs in the world. There are severe psychological, and medical consequences from methamphetamine misuse and abuse. This poses a particular challenge for clinicians treating patients for mental health conditions that are comorbid with substance use disorder (SUD). This is especially challenging when there are also interactions that can alter or influence psychiatric medications used to treat these patients. Questions such as the following arise: Given the high comorbidity of SUD with ADHD, how often should you check drug screens, and what is the threshold for discontinuing the stimulants if tests come back positive? In this podcast episode, Dr. William Sauve’ addresses these concerns, and much more. He also employs strategies to improve communication with patients about being transparent when it comes to using substances.

Optional CME credits / certificate instructions: After listening to the podcast, to take the optional posttest and receive CME credit, click HERE.

Learning Objectives: After completing this educational activity, you should be better able to:

  • Manage the challenges associated with psychiatric treatment of conditions comorbid with substance use disorder
  • Integrate psychiatric drug interactions with methamphetamine use
  • Assess treatments approaches for conditions associated with long-term use of methamphetamines

Accreditation and Credit Designation Statements: The Neuroscience Education Institute (NEI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NEI designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A posttest score of 70% or higher is required to receive CME credit.

Nurses and Physician Assistants: for your CE requirements, the ANCC and NCCPA will accept AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME. The content in this activity pertains to pharmacology and is worth 0.50 continuing education hour of pharmacotherapeutics.

Peer Review: The content was peer-reviewed by an MD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME activity.

Disclosures: All individuals in a position to influence or control content are required to disclose all relevant financial relationships. Although potential conflicts of interest are identified and resolved prior to the activity being presented, it remains for the participant to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.

Faculty Interviewer

Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY

Grant/Research: Acadia, Alkermes, Allergan, Axsome, Biohaven, Intra-Cellular, Lundbeck, Novartis, Otsuka, Sage, Sunovion, Tris

Consultant/Advisor: Acadia, AiCure, Alfasigma, Alkermes, Allergan, Avanir, Intra-Cellular, Ironshore, Janssen, Lundbeck, MedAvante-ProPhase, Neurocrine, Novartis, Otsuka, Sage, Sunovion, Takeda, Teva, Tris

Speakers Bureau: Acadia, Alkermes, Allergan, Avanir, Ironshore, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Takeda, Teva, Tris

Faculty Interviewee

William M. Sauvé, MD

Regional Medical Director, Greenbrook TMS NeuroHealth Centers, Virginia

Speakers Bureau: Avanir

Author

Sabrina K. Bradbury-Segal, PhD

Medical Writer, Neuroscience Education Institute, Carlsbad, CA

No financial relationships to disclose.

The Planning Committee and Peer Reviewer have no financial relationships to disclose.

Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.

Cultural and Linguistic Competency: A variety of resources addressing cultural and linguistic competency can be found in this linked handout.

Support: This activity is supported solely by the provider, NEI.

Released: June 8, 2020 CME credit expires: June...

bookmark
plus icon
share episode

Show more

Toggle view more icon

FAQ

How many episodes does NEI Podcast have?

NEI Podcast currently has 186 episodes available.

What topics does NEI Podcast cover?

The podcast is about Suicide, Health & Fitness, Ptsd, Neuroscience, Anxiety, Pediatrics, Depression, Mentalhealth, Medicine, Neurology, Podcasts, Adhd, Education, Brain and Psychiatry.

What is the most popular episode on NEI Podcast?

The episode title 'E156 - The PsychopharmaStahlogy Show: The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment' is the most popular.

What is the average episode length on NEI Podcast?

The average episode length on NEI Podcast is 31 minutes.

How often are episodes of NEI Podcast released?

Episodes of NEI Podcast are typically released every 13 days, 12 hours.

When was the first episode of NEI Podcast?

The first episode of NEI Podcast was released on May 21, 2017.

Show more FAQ

Toggle view more icon

Comments

0.0

out of 5

Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey Icon
Star filled grey Icon

Rating

Star iconStar iconStar iconStar iconStar icon

Review or comment on this podcast...

Post

External Reviews

Imported reviews from Apple Podcasts.
















Generate a badge

Get a badge for your website that links back to this

Select type & size
Open dropdown icon
share badge image

Copy